09:56 AM EDT, 04/10/2025 (MT Newswires) -- Ginkgo Bioworks Holdings ( DNA ) said Thursday the Advanced Research Projects Agency for Health has awarded the company and its partners a $29 million contract for a project to stabilize and reshore supply chains for essential pharmaceuticals.

The company and its partners, Tritica Biosciences, US Pharmacopeia, On Demand Pharmaceuticals and Isolere Bio by Donaldson, will use wheat germ cell-free expression systems to develop distributed manufacturing of essential medicines under the two-year program, Ginkgo Bioworks ( DNA ) said.

The strategy moves the production of active pharmaceutical ingredients to a "robust" and decentralized system from "fragile" global supply chains, the company said.

Price: 6.56, Change: -0.23, Percent Change: -3.32